Averin Capital

VC AI focus New York, United States · Founded 2024

Website Claimed by the investor Work there? Request access

Averin Capital backs and builds early-stage companies transforming human health through AI and breakthrough technologies. Founded in 2024, the firm is based in New York. Its five investment areas are foundational science, physical AI, care delivery, healthcare infrastructure, and human performance. Averin invests at pre-seed, seed, Series A, and later stages across the US, Europe, and Asia. Typical initial investments range from $500,000 to $10 million, and the firm sometimes leads rounds. Public portfolio: https://www.averincapital.com/companies

About Averin Capital

Averin Capital backs and builds early-stage companies transforming human health through AI and breakthrough technologies. Founded in 2024. Public portfolio: https://www.averincapital.com/companies

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Share your experience

At a glance

Type VC

Stages Pre-Seed, Seed, Series A

Check size $500k-$10M$500,000–$10 million typical initial investment. Sometimes leads rounds.

Sub-verticals AI/ML in Healthcare, Digital Health

HQ New York, United States

Founded 2024

Lead / follow Both

Visit website

Healthcare AI tools backed by Averin Capital

Tools made by companies in Averin Capital's portfolio that we cover in the directory.

Genius AI Detection

Hologic

Oncology AI

Hologic's Genius AI Detection is a deep learning-based software that assists radiologists in the early detection of breast cancer by identifying suspicious lesions in breast tomosynthesis images, reducing false positives, and optimizing workflow.

Quantra

HOLOGIC

Oncology AI

Hologic Quantra 2.2 is an FDA-cleared AI-powered software that automates and standardizes breast density assessment from mammography images, categorizing breast tissue according to BI-RADS guidelines to aid radiologists.

Contact vendor for pricing

Genius AI Detection 2.0 with CC-MLO Correlation

Hologic

Oncology AI

Hologic Genius AI Detection 2.0 with CC-MLO Correlation is an FDA-cleared AI-powered software for digital breast tomosynthesis, designed to enhance breast cancer detection by identifying suspicious lesions and correlating findings across CC and MLO views, improving diagnostic accuracy and workflow efficiency for radiologists.

M1000 IMAGECHECKER

Hologic

Oncology AI

Hologic's M1000 ImageChecker is an FDA-cleared computer-aided detection (CAD) system that assists radiologists in identifying suspicious areas on mammograms, such as microcalcifications and masses, to aid in the early detection of breast cancer.

Genius Digital Diagnostics System with the Genius Cervical AI algorithm

Hologic

OB/GYN AI

Hologic's Genius™ Digital Diagnostics System with the Genius™ Cervical AI algorithm is the first and only FDA-cleared digital cytology system, combining AI with advanced volumetric imaging to enhance cervical cancer screening, improve detection of precancerous lesions and cancer cells, and optimize laboratory workflows.

Silna Health

General Productivity (AI Assistants)

Silna Health is an AI-powered care readiness platform that automates prior authorizations, benefit checks, and insurance monitoring to streamline administrative processes for healthcare providers.

Custom / enterprise